Intelligent Machine Age: Advancing Robotics, Automation, Semiconductors, and Next-Gen Space & Automotive Technologies

Danilo Bzdok Profile

Danilo Bzdok

Danilo Bzdok

Biography

PhD in computer science (very good) in machine-learning at Neurospin/INRIA Saclay, Paris, France, and Heinrich-Heine University, D?sseldorf, Germany
Mathematical studies at Heinrich-Heine University in D?sseldorf, Germany
Calculus, linear algebra, numerical analysis, probability theory, convex optimization
PhD in cognitive neuroscience (with distinction), DFG-IRTG 1328, RWTH
Medical studies at RWTH Aachen, Universit? de Lausanne, and Harvard Medical School (psychiatry, ?high honors?)
?    German national medical examinations; grade: good
?    American national premedical examination (USMLE step 1); scores: 91, 219
?    German national premedical examination; top 5% of class
High school diploma; focus on math and computer science

Research Interest

Associate Editor for "Systems Neuroscience, 2020 ? 2024 Lecture: "Machine-learning for Biomedical Data", School of Computer Science, McGill University 2015 ? 2019 Lecture: "Machine-learning in Medicine und Psychology", RWTH Aachen

Abstract

Machine learning paradigms for single subject prediction The nature of mental illness remains a conundrum. Traditional disease categories are increasingly suspected to misrepresent the causes underlying mental disturbance. Yet psychiatrists and investigators now have an unprecedented opportunity to benefit from complex patterns in brain, behavior, and genes using methods from machine learning (e.g., support vector machines, modern neural-network algorithms, cross-validation procedures). Combining these analysis techniques with a wealth of data from consortia and repositories has the potential to advance a biologically grounded redefinition of major psychiatric disorders. Increasing evidence suggests that data-derived subgroups of psychiatric patients can better predict treatment outcomes than DSM/ICD diagnoses can. In a new era of evidence-based psychiatry tailored to single patients, objectively measurable endophenotypes could allow for early disease detection, individualized treatment selection, and dosage adjustment to reduce the burden of disease. This primer aims to introduce clinicians and researchers to the opportunities and challenges in bringing machine intelligence into psychiatric practice.